KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Preferred Stock Liabilities (2020 - 2023)

LifeMD's Preferred Stock Liabilities history spans 4 years, with the latest figure at $5.0 million for Q2 2023.

  • For Q2 2023, Preferred Stock Liabilities rose 16.06% year-over-year to $5.0 million; the TTM value through Jun 2023 reached $5.0 million, up 16.06%, while the annual FY2022 figure was $4.6 million, 11.07% up from the prior year.
  • Preferred Stock Liabilities reached $5.0 million in Q2 2023 per LFMD's latest filing, up from $4.7 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $5.0 million in Q2 2023 to a low of $3.7 million in Q4 2020.
  • Average Preferred Stock Liabilities over 4 years is $4.2 million, with a median of $4.2 million recorded in 2022.
  • The largest YoY upside for Preferred Stock Liabilities was 16.06% in 2023 against a maximum downside of 10.77% in 2023.
  • A 4-year view of Preferred Stock Liabilities shows it stood at $3.7 million in 2020, then grew by 12.45% to $4.1 million in 2021, then grew by 11.07% to $4.6 million in 2022, then increased by 10.23% to $5.0 million in 2023.
  • Per Business Quant, the three most recent readings for LFMD's Preferred Stock Liabilities are $5.0 million (Q2 2023), $4.7 million (Q1 2023), and $4.6 million (Q4 2022).